Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
20 earlier
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2576-2577)
Original title: “SRES 182: A resolution supporting the goals and ideals of National Public Health Week.”
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
Original title: “HR 2591: Mental Health in Aviation Act of 2025”
Referred to the House Committee on the Judiciary.
Original title: “HR 2502: Law Enforcement Training for Mental Health Crisis Response Act of 2025”
ASSUMING FIRST SPONSORSHIP - Mr. Murphy asked unanimous consent that he may hereafter be considered as the first sponsor of H.R. 2433, a bill originally introduced by Representative Green (TN), for the purpose of adding cosponsors and requesting reprintings pursuant to clause 7 of rule XII. Agreed to without objection.
Original title: “HR 2433: Reducing Medically Unnecessary Delays in Care Act of 2025”
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Original title: “HR 2199: Restore Protections for Dialysis Patients Act”
Referred to the House Committee on Energy and Commerce.
Original title: “HR 2106: Expanding Medical Education Act”
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Original title: “HRES 119: Declaring racism a public health crisis.”
Referred to the House Committee on Ways and Means.
Original title: “HR 996: Paid Family and Medical Leave Tax Credit Extension and Enhancement Act”
Ordered to be Reported in the Nature of a Substitute (Amended) by Unanimous Consent.
Original title: “HR 741: Stronger Engagement for Indian Health Needs Act of 2025”
Referred to the House Committee on Energy and Commerce.
Original title: “HRES 67: Recognizing the roles and the contributions of Americas Certified Registered Nurse Anesthetists (CRNAs) and their critical role in providing quality health care for the public and the Nation's Armed Forces for more than 150 years and through multiple public health emergencies and beyond.”
U.S. Government releases first national One Health plan to protect from shared health threats.
Original title: “U.S. Government Releases First National One Health Plan to Protect People, Animals, and Our Environment from Shared Health Threats”
Referred to the House Committee on Ways and Means.
Original title: “HR 247: Health Care Affordability Act of 2025”
Read twice and referred to the Committee on Finance.
Original title: “S 46: Health Care Affordability Act of 2025”
Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation for people 65 years and older and those who are moderately or severely immunocompromised to receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose.
Original title: “CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised”
Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation for lowering the age for pneumococcal vaccination from 65 to 50 years old.
Original title: “CDC Recommends Lowering the Age for Pneumococcal Vaccination from 65 to 50 Years Old”